Precigen (PGEN) Enterprise Value (2011 - 2026)
Precigen (PGEN) reported Enterprise Value of -$56.2 million for Q1 2026, down 10.89% year-over-year from -$63.1 million in Q1 2025, and up 42.52% quarter-over-quarter from -$97.9 million in Q4 2025.
Precigen (PGEN) Enterprise Value (2011 - 2026) Analysis & Trends
Precigen (PGEN) has 16 years of Enterprise Value data on file, last reported at -$56.2 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$56.2 million, down 10.89% year-over-year; the trailing twelve-month figure through Mar 2026 was -$56.2 million (down 10.89% YoY), and the FY2025 annual result was -$97.9 million, down 40.41% from the prior year.
- Enterprise Value climbed to -$56.2 million in Q1 2026 per PGEN's latest filing, from -$97.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$10.1 million in Q3 2023 and troughed at -$121.1 million in Q3 2025.
- A 5-year average of -$54.1 million and a median of -$50.7 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value soared 85.87% in 2023, then plunged 323.09% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$48.2 million in 2022, then plunged by 30.41% to -$62.9 million in 2023, then dropped by 10.88% to -$69.7 million in 2024, then tumbled by 40.41% to -$97.9 million in 2025, then soared by 42.52% to -$56.2 million in 2026.
- Business Quant data shows PGEN's Enterprise Value at -$56.2 million in Q1 2026, -$97.9 million in Q4 2025, and -$121.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | -56.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.25 Mn |
| Dec 31, 2025 | -97.86 Mn |
| Sep 30, 2025 | -121.14 Mn |
| Jun 30, 2025 | -28.87 Mn |
| Mar 31, 2025 | -50.72 Mn |
| Dec 31, 2024 | -69.69 Mn |
| Sep 30, 2024 | -28.63 Mn |
| Jun 30, 2024 | -19.54 Mn |
| Mar 31, 2024 | -44.76 Mn |
| Dec 31, 2023 | -62.86 Mn |
| Sep 30, 2023 | -10.08 Mn |
| Jun 30, 2023 | -16.55 Mn |
| Mar 31, 2023 | -23.54 Mn |
| Dec 31, 2022 | -48.20 Mn |
| Sep 30, 2022 | -71.33 Mn |
| Jun 30, 2022 | -115.30 Mn |
| Mar 31, 2022 | -54.12 Mn |
| Dec 31, 2021 | -108.66 Mn |
| Sep 30, 2021 | -114.41 Mn |
| Jun 30, 2021 | -115.11 Mn |